Internal Medicine Alert - November 30, 2012

Target Audience:

This CME activity is intended for the internist/family physician.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Internal Medicine Alert has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/01/12. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of each issue.

Faculty Listing:

Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Executive Editor
Leslie Coplin

Managing Editor
Neill Kimball

Associate Editors
William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Louis Kuritzky, MD

Clinical Assistant Professor
University of Florida
Gainesville

Authors
Jeffrey T. Jensen, MD, MPH
Leon Speroff Professor and Vice Chair for Research
Department of Obstetrics and Gynecology
Oregon Health & Science University
Portland

William B. Ershler, MD
INOVA Fairfax Hospital Cancer Center
Fairfax, VA;
Director
Institute for Advanced Studies in Aging
Washington, DC

Michael Rubin, MD
Professor of Clinical Neurology
Weill Cornell Medical College
New York, NY

Peer reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Subjects:

  • Bariatric Surgery Reduces the Risk of Type 2 Diabetes
  • Cognitive Function in Breast Cancer Survivors
  • Controlling Diabetic Neuropathic Pain
  • Tbo-filgrastim Injection
  • Risk of Cancer in RA Patients Treated with Disease-Modifying Drugs
  • A Different Kind of Fish Story
  • Antidepressants and Auto Accidents

Objectives:

  • describe new findings in differential diagnosis and treatment of various diseases
  • describe the advantages, disadvantages and controversies surrounding the latest advances in the diagnosis and treatment of disease
  • identify cost-effective treatment regimens
  • explain the advantages and disadvantages of new disease screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, serves on the advisory board for Lilly, Boehringer Ingelheim, Novo Nordisk, Sunovion, and Teva; he serves on the speakers bureau of Boehringer Ingelheim, Lilly, Kowa, Novo Nordisk, and Teva.

Associate editors William T. Elliott, MD, FACP, and James Chan, PharmD, PhD, Authors William B. Ershler, MD and Michael Rubin, MD, Peer reviewer Gerald Roberts, MD; executive editor Leslie Coplin; and managing editor Neill Kimball report no financial relationships relevant to this field of study.

Associate editor Louis Kuritzky, MD is an advisor for Endo, Kowa, Pricara, and Takeda.

Author Jeffrey T. Jensen, MD, MPH is a consultant for Agile Pharmaceuticals, Bayer Healthcare, HRA Pharma, and Merck; is a speaker for Bayer Healthcare and Merck; and receives research support from Agile Pharmaceuticals, Abbott Pharmaceuticals, Bayer Healthcare, HRA Pharma, and Medicines360.

Copyright 2012 AHC Media. All rights reserved.